Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Memoria de Actividades.
ONT 2001.
Rev Esp Trasp, 11 (2002), pp. 58-78
[2.]
International data on organ donation and transplantation activities in 1999.
Newsletter Transplant, 5 (2000), pp. 18-19
[3.]
Anuario Estadístico de Accidentes 1998.
[4.]
Memoria de Actividades.
ONT 2001.
Rev Esp Trasp, 11 (2002), pp. 37-39
[5.]
Cuarta Memoria de Resultados del Registro Español de Trasplante Hepático 1984-2000. Disponible en: http://www.msc.es/ont
[6.]
European Liver Transplant Registry. Disponible en: http://www.eltr.org
[7.]
UNOS data Registry. Disponible en: http://www.unos.org
[8.]
V. Cuervas-Mons, C. Barrios.
Trasplante hepático.
Rev Esp Enferm Dig, 194 (1994), pp. 235-240
[9.]
I. Cirera, M. Navasa, H. Andreu, J.C. García-Valdecasas, L. Grande.
Indicaciones y contraindicaciones del trasplante hepático.
Gastroenterol Hepatol, 19 (1996), pp. 394-400
[10.]
M.R. Lucey, K.A. Brown, G.T. Everson, J.J. Fung, R. Gish, E.B. Keeffe, et al.
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.
Liver Transpl Surg, 3 (1997), pp. 628-637
[11.]
J. Devlin, J. O’Grady.
Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.
Gut, 45 (1999), pp. 1-22
[12.]
J.r. Carithers RL.
Liver transplantation. American Association for the Study of Liver Diseases.
Liver Transpl, 6 (2000), pp. 122-135
[13.]
W.R. Kim, E.R. Dickson.
Timing of liver transplantation.
Semin Liver Dis, 20 (2000), pp. 451-464
[14.]
A. Propst, T. Propst, G. Zangerl, D. Ofner, G. Judmaier, W. Vogel.
Prognosis and life expectancy in chronic liver disease.
Dig Dis Sci, 40 (1995), pp. 1805-1815
[15.]
M. Oellerich, M. Burdelski, H.U. Lautz, L. Binder, R. Pichlmayr.
Predictors of one-year pretransplant survival in patients with cirrhosis.
Hepatology, 14 (1991), pp. 1029-1034
[16.]
J. Bustamante, A. Rimola, P.J. Ventura, M. Navasa, I. Cirera, V. Reggiardo, et al.
Prognostic significance of hepatic encephalopathy in patients with cirrhosis.
J Hepatol, 30 (1999), pp. 890-895
[17.]
H. Ring-Larsen.
Treatment of refractory ascites in cirrhosis.
Ascites and renal dysfunction in Liver disease, pp. 480-491
[18.]
A. Ginés, A. Escorsell, P. Ginés, J. Salo, W. Jiménez, L. Inglada, et al.
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.
Gastroenterology, 105 (1993), pp. 229-236
[19.]
V. Arroyo, R. Bataller, M. Guevara.
Treatment of hepatorenal syndrome in cirrhosis.
Ascites and renal dysfunction in liver disease, pp. 492-510
[20.]
L. Tito, A. Rimola, P. Ginés, J. Llach, V. Arroyo, J. Rodés.
Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors.
Hepatology, 8 (1988), pp. 27-31
[21.]
C. Altman, J.D. Grange, X. Amiot, G. Pelletier, F. Lacaine, F. Bodin, et al.
Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation.
J Gastroenterol Hepatol, 10 (1995), pp. 47-50
[22.]
M. Navasa, J.C. García-Pagán, J. Bosch, J. Rodés.
Valor pronóstico del aclaramiento hepático del verde de indocianina en pacientes con cirrosis hepática y hemorragia por varices esofágicas.
Med Clin (Barc), 98 (1992), pp. 290-294
[23.]
H.R. Rosen, C.R. Shackleton, P. Martin.
Indications for and timing of liver transplantation.
Med Clin North Am, 80 (1996), pp. 1069-1102
[24.]
E.B. Keeffe.
Selection of patients for liver transplantation.
Transplantation of the liver 2nd ed, pp. 13-60
[25.]
I. Penn.
Evaluation of the candidate with a previous malignancy.
Liver Transpl Surg, 2 (1996), pp. 109-113
[26.]
D.R. Jeyarajah, M. McBride, G.B. Klintmalm, T.A. Gonwa.
Combined liver-kidney transplantation: what are the indications?.
Transplantation, 64 (1997), pp. 1091-1096
[27.]
P.A. Lange, J.K. Stoller.
The hepatopulmonary syndrome. Effect of liver transplantation.
Clin Chest Med, 17 (1996), pp. 115-123
[28.]
M.A. Ramsay, B.R. Simpson, A.T. Nguyen, K.J. Ramsay, C. East, G.B. Klintmalm.
Severe pulmonary hypertension in liver transplant candidates.
Liver Transpl Surg, 3 (1997), pp. 494-500
[29.]
A. Erice, F.S. Rhame, R.C. Heussner, D.L. Dunn, H.H. Balfour Jr..
Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review.
Rev Infect Dis, 13 (1991), pp. 537-547
[30.]
A.A. Prachalias, A. Pozniak, C. Taylor, P. Srinivasan, P. Muiesan, J. Wendon, et al.
Liver transplantation in adults coinfected with HIV.
Transplantation, 72 (2001), pp. 1684-1688
[31.]
P. Paliard, F. Mion, O. Boillot.
Liver transplantation for alcoholic cirrhosis. Selective indications.
Presse Med, 24 (1995), pp. 859-862
[32.]
D. Samuel, R. Muller, G. Alexander, L. Fassati, B. Ducot, J.P. Benhamou, et al.
Liver transplantation in European patients with the hepatitis B surface antigen.
N Engl J Med, 329 (1993), pp. 1842-1847
[33.]
V.G. Bain, N.M. Kneteman, M.M. Ma, K. Gutfreund, J.A. Shapiro, K. Fischer, et al.
Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation.
Transplantation, 62 (1996), pp. 1456-1462
[34.]
C. Trey, C.S. Davidson.
The management of fulminant hepatic failure.
Prog Liver Dis, 3 (1970), pp. 282-298
[35.]
A. Mas, J. Rodés.
Fulminant hepatic failure.
Lancet, 349 (1997), pp. 1081-1085
[36.]
J.G. O’Grady, G.J. Alexander, K.M. Hayllar, R. Williams.
Early indicators of prognosis in fulminant hepatic failure.
Gastroenterology, 97 (1989), pp. 439-445
[37.]
J. Bernuau, B. Rueff, J.P. Benhamou.
Fulminant and subfulminant liver failure: definitions and causes.
Semin Liver Dis, 6 (1986), pp. 97-106
[38.]
J.G. O’Grady, S.W. Schalm, R. Williams.
Acute liver failure: redefining the syndromes.
Lancet, 342 (1993), pp. 273-275
[39.]
A. Mas.
Complicaciones extrahepáticas en la insuficiencia hepática aguda grave.
Controversias en hepatología, pp. 362-365
[40.]
J. Bernuau, J.P. Benhamou.
Fulminant and subfulminant liver failure.
Oxford textbook of clinical hepatology. 2nd edition, pp. 1341-1372
[41.]
J. Bernuau, D. Samuel, F. Durand, F. Saliba, M. Bourliére, R. Adam, et al.
Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V (FV) below 50% of normal: a prospective study [abstract].
Hepatology, 14 (1991), pp. 49
[42.]
A. Pauwels, N. Mostefa-Kara, C. Florent, V.G. Levy.
Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria.
J Hepatol, 17 (1993), pp. 124-127
[43.]
S.M. Riordan, R. Williams.
Use and validation of selection criteria for liver transplantation in acute liver failure.
Liver Transpl, 6 (2000), pp. 170-173
[44.]
A. Castells, J.M. Salmerón, M. Navasa, A. Rimola, J. Saló, H. Andreu, et al.
Liver transplantation for acute liver failure: analysis of applicability.
Gastroenterology, 105 (1993), pp. 532-538
[45.]
T. Poynard, S. Naveau, M. Doffoel, K. Boudjema, C. Vanlemmens, G. Mantion, et al.
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group.
J Hepatol, 30 (1999), pp. 1130-1137
[46.]
G.P. Pageaux, J. Michel, V. Coste, P. Perney, P. Possoz, P.F. Perrigault, et al.
Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism.
Gut, 45 (1999), pp. 421-426
[47.]
C. Duvoux, I. Delacroix, J.P. Richardet, F. Roudot-Thoraval, J.M. Metreau, P.L. Fagniez, et al.
Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis.
Transplantation, 67 (1999), pp. 418-421
[48.]
R.M. Weinrieb, D.H. Van Horn, A.T. McLellan, M.R. Lucey.
Interpreting the significance of drinking by alcohol-dependent liver transplant patients: fostering candor is the key to recovery.
Liver Transpl, 6 (2000), pp. 769-776
[49.]
E.B. Keeffe.
Comorbidities of alcoholic liver disease that affect outcome of orthotopic liver transplantation.
Liver Transpl Surg, 3 (1997), pp. 251-257
[50.]
G. Realdi, G. Fattovich, S. Hadziyannis, S.W. Schalm, P. Almasio, J. Sánchez-Tapias, et al.
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP).
J Hepatol, 21 (1994), pp. 656-666
[51.]
H.R. Rosen, P. Martin.
Hepatitis B and C in the liver transplant recipient.
Semin Liver Dis, 20 (2000), pp. 465-480
[52.]
S.E. Davies, B.C. Portmann, J.G. O’Grady, P.M. Aldis, K. Chaggar, G.J. Alexander, et al.
Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.
Hepatology, 13 (1991), pp. 150-157
[53.]
D. Shouval, D. Samuel.
Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review.
Hepatology, 32 (2000), pp. 1189-1195
[54.]
A. Sánchez-Fueyo, A. Rimola, L. Grande, J. Costa, A. Mas, M. Navasa, et al.
Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.
Hepatology, 31 (2000), pp. 496-501
[55.]
P.W. Angus, G.W. McCaughan, E.J. Gane, D.H. Crawford, H. Harley.
Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.
Liver Transpl, 6 (2000), pp. 429-433
[56.]
J.P. Villeneuve, L.D. Condreay, B. Willems, G. Pomier-Layrargues, D. Fenyves, M. Bilodeau, et al.
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B.
Hepatology, 31 (2000), pp. 207-210
[57.]
T. Poynard, P. Bedossa, P. Opolon.
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
Lancet, 349 (1997), pp. 825-832
[58.]
G. Fattovich, G. Giustina, F. Degos, F. Tremolada, G. Diodati, P. Almasio, et al.
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.
Gastroenterology, 112 (1997), pp. 463-472
[59.]
M. Prieto, M. Berenguer, J.M. Rayón, J. Córdoba, L. Argüello, D. Carrasco, et al.
High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Hepatology, 29 (1999), pp. 250-256
[60.]
L.K. Schluger, P.A. Sheiner, S.N. Thung, J.Y.N. Lau, A. Min, D.C. Wolf, et al.
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation.
Hepatology, 23 (1996), pp. 971-976
[61.]
L.M. Forman, J.D. Lewis, J.A. Berlin, H.I. Feldman, M.R. Lucey.
The association between hepatitis C infection and survival after orthotopic liver transplantation.
Gastroenterology, 122 (2002), pp. 889-896
[62.]
M. Berenguer, M. Prieto, F. San-Juan, J.M. Rayón, F. Martínez, D. Carrasco, et al.
Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.
Hepatology, 36 (2002), pp. 202-210
[63.]
E.J. Gane, B.C. Portmann, N.V. Naoumov, H.M. Smith, J.A. Underhill, P.T. Donaldson, et al.
Long-term outcome of hepatitis C infection after liver transplantation.
N Engl J Med, 334 (1996), pp. 815-820
[64.]
A.J. Czaja, J.E. Hay, J. Rakela.
Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis.
Mayo Clin Proc, 65 (1990), pp. 23-30
[65.]
V. Ratziu, D. Samuel, M. Sebagh, O. Farges, F. Saliba, P. Ichai, et al.
Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease.
J Hepatol, 30 (1999), pp. 131-141
[66.]
E. Prados, V. Cuervas-Mons, M. De la Mata, E. Fraga, A. Rimola, M. Prieto, et al.
Outcome of autoimmune hepatitis after liver transplantation.
Transplantation, 66 (1998), pp. 1645-1650
[67.]
C. Niederau, R. Fischer, A. Purschel, W. Stremmel, D. Haussinger, G. Strohmeyer.
Long-term survival in patients with hereditary hemochromatosis.
Gastroenterology, 110 (1996), pp. 1107-1119
[68.]
C. Niederau, R. Fischer, A. Sonnenberg, W. Stremmel, H.J. Trampisch, G. Strohmeyer.
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.
N Engl J Med, 313 (1985), pp. 1256-1262
[69.]
D.J. Brandhagen.
Liver transplantation for hereditary hemochromatosis.
Liver Transpl, 7 (2001), pp. 663-672
[70.]
E.B. Keeffe.
Liver transplantation in patients with hepatic iron overload: favorable or unfavorable outcome?.
Hepatology, 32 (2000), pp. 1396-1398
[71.]
B. Eghtesad, N. Nezakatgoo, L.C. Geraci, N. Jabbour, W.D. Irish, W. Marsh, et al.
Liver transplantation for Wilson’s disease: a single-center experience.
Liver Transpl Surg, 5 (1999), pp. 467-474
[72.]
M. De la Mata, J.L. Montero, E. Fraga, M. Delgado, G. Costán, J. Padillo, et al.
Indicaciones y resultados del trasplante hepático en las enfermedades colestásicas.
Gastroenterol Hepatol, 23 (2000), pp. 39-42
[73.]
R.E. Poupon, K.D. Lindor, K. Cauch-Dudek, E.R. Dickson, R. Poupon, E.J. Heathcote.
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.
Gastroenterology, 113 (1997), pp. 884-890
[74.]
T.M. Pasha, E.R. Dickson.
Survival algorithms and outcome analysis in primary biliary cirrhosis.
Semin Liver Dis, 17 (1997), pp. 147-158
[75.]
J. Neuberger.
Transplantation for primary biliary cirrhosis.
Semin Liver Dis, 17 (1997), pp. 137-146
[76.]
M. Navasa, A. Parés, M. Bruguera, J. Caballería, J. Bosch, J. Rodés.
Portal hypertension in primary biliary cirrhosis. Relationship with histological features.
J Hepatol, 5 (1987), pp. 292-298
[77.]
R.F. Liermann García, G.C. Evangelista, P. McMaster, J. Neuberger.
Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center.
Hepatology, 33 (2001), pp. 22-27
[78.]
M. Navasa, X. Forns, V. Sánchez, H. Andreu, V. Marcos, J.M. Borrás, et al.
Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation.
J Hepatol, 25 (1996), pp. 129-134
[79.]
D.M. Harnois, K.D. Lindor.
Primary sclerosing cholangitis: evolving concepts in diagnosis and treatment.
Dig Dis, 15 (1997), pp. 23-41
[80.]
J.M. Farrant, K.M. Hayllar, M.L. Wilkinson, J. Karani, B.C. Portmann, D. Westaby, et al.
Natural history and prognostic variables in primary sclerosing cholangitis.
Gastroenterology, 100 (1991), pp. 1710-1717
[81.]
E.R. Dickson, P.A. Murtaugh, R.H. Wiesner, P.M. Grambsch, T.R. Fleming, J. Ludwig, et al.
Primary sclerosing cholangitis: refinement and validation of survival models.
Gastroenterology, 103 (1992), pp. 1893-1901
[82.]
A. Bergquist, H. Glaumann, B. Persson, U. Broome.
Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
Hepatology, 27 (1998), pp. 311-316
[83.]
I.W. Graziadei, R.H. Wiesner, P.J. Marotta, M.K. Porayko, J.E. Hay, M.R. Charlton, et al.
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
Hepatology, 30 (1999), pp. 1121-1127
[84.]
K. Okuda, T. Ohtsuki, H. Obata, M. Tomimatsu, N. Okazaki, H. Hasegawa, et al.
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients.
Cancer, 56 (1985), pp. 918-928
[85.]
X. Calvet, J. Bruix, P. Ginés, C. Bru, M. Solé, R. Vilana, et al.
Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients.
Hepatology, 12 (1990), pp. 753-760
[86.]
M. Ebara, M. Ohto, T. Shinagawa, N. Sugiura, K. Kimura, S. Matsutani, et al.
Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients.
Gastroenterology, 90 (1986), pp. 289-298
[87.]
L. Barbara, G. Benzi, S. Gaiani, F. Fusconi, G. Zironi, S. Siringo, et al.
Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival.
Hepatology, 16 (1992), pp. 132-137
[88.]
T. Livraghi, L. Bolondi, L. Buscarini, M. Cottone, A. Mazziotti, A. Morabito, et al.
No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group.
J Hepatol, 22 (1995), pp. 522-526
[89.]
V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, F. Bozzetti, et al.
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.
N Engl J Med, 334 (1996), pp. 693-699
[90.]
J. Figueras, E. Jaurrieta, C. Valls, C. Benasco, A. Rafecas, X. Xiol, et al.
Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
Hepatology, 25 (1997), pp. 1485-1489
[91.]
J.M. Llovet, J. Bruix, J. Fuster, A. Castells, J.C. García-Valdecasas, L. Grande, et al.
Liver transplantation for small hepatocellular carcinoma: the tumor – node-metastasis classification does not have prognostic power.
Hepatology, 27 (1998), pp. 1572-1577
[92.]
F.Y. Yao, L. Ferrell, N.M. Bass, J.J. Watson, P. Bacchetti, A. Venook, et al.
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.
Hepatology, 33 (2001), pp. 1394-1403
[93.]
W.J. Wall, P.J. Marotta.
Surgery and transplantation for hepatocellular cancer.
Liver Transpl, 6 (2000), pp. 16-22
[94.]
J. Belghiti, Y. Panis, O. Farges, J.P. Benhamou, F. Fekete.
Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis.
Ann Surg, 214 (1991), pp. 114-117
[95.]
B. Ringe, C. Wittekind, A. Weimann, G. Tusch, R. Pichlmayr.
Results of hepatic resection and transplantation for fibrolamellar carcinoma.
Surg Gynecol Obstet, 175 (1992), pp. 299-305
[96.]
F.A. Casavilla, J.W. Marsh, S. Iwatsuki, S. Todo, R.G. Lee, J.R. Madariaga, et al.
Hepatic resection and transplantation for peripheral cholangiocarcinoma.
J Am Coll Surg, 185 (1997), pp. 429-436
[97.]
C.G. Meyer, I. Penn, L. James.
Liver transplantation for cholangiocarcinoma: results in 207 patients.
Transplantation, 69 (2000), pp. 1633-1637
[98.]
I. De Vreede, J.L. Steers, P.A. Burch, C.B. Rosen, L.L. Gunderson, M.G. Haddock, et al.
Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.
Liver Transpl, 6 (2000), pp. 309-316
[99.]
T. Lehnert.
Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients.
Transplantation, 66 (1998), pp. 1307-1312
[100.]
Y.P. Le Treut, J.R. Delpero, B. Dousset, D. Cherqui, P. Segol, G. Mantion, et al.
Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report.
Ann Surg, 225 (1997), pp. 355-364
[101.]
K. Swenson, P. Seu, M. Kinkhabwala, M. Maggard, P. Martin, J. Goss, et al.
Liver transplantation for adult polycystic liver disease.
Hepatology, 28 (1998), pp. 412-415
[102.]
P. Parrilla, P. Ramírez, L.F. Andreu, S.F. Bueno, R. Robles, M. Miras, et al.
Long-term results of liver transplantation in familial amyloidotic polyneuropathy type I.
Transplantation, 64 (1997), pp. 646-649
[103.]
E.A. Pomfret, W.D. Lewis, R.L. Jenkins, P. Bergethon, S.W. Dubrey, J. Reisinger, et al.
Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy.
Transplantation, 65 (1998), pp. 918-925
[104.]
E. Monteiro, R. Perdigoto, A.L. Furtado.
Liver transplantation for familial amyloid polyneuropathy.
Hepatogastroenterology, 45 (1998), pp. 1375-1380
[105.]
O.B. Suhr, Y. Ando, G. Holmgren, L. Wikstrom, S. Friman, G. Herlenius, et al.
Liver transplantation in familial amyloidotic polyneuropathy (FAP). A comparative study of transplanted and non-transplanted patient’s survival.
Transpl Int, 11 (1998), pp. 160-163
[106.]
P. Cochat.
Primary hyperoxaluria type 1.
Kidney Int, 55 (1999), pp. 2533-2547
[107.]
M. Broyer, F.P. Brunner, H. Brynger, S.R. Dykes, J.H. Ehrich, W. Fassbinder, et al.
Kidney transplantation in primary oxalosis: data from the EDTA Registry.
Nephrol Dial Transplant, 5 (1990), pp. 332-336
[108.]
N.V. Jamieson.
The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984-1997 The European PH1 transplant registry report. European PH1 Transplantation Study Group.
J Nephrol, 11 (1998), pp. 36-41
[109.]
M.J. Kemper, D. Nolkemper, X. Rogiers, K. Timmermann, E. Sturm, M. Malago, et al.
Preemptive liver transplantation in primary hyperoxaluria type 1: timing and preliminary results.
J Nephrol, 11 (1998), pp. 46-48
[110.]
A.W. Hemming, B. Langer, P. Greig, B.R. Taylor, R. Adams, E.J. Heathcote.
Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation.
Am J Surg, 171 (1996), pp. 176-180
[111.]
B. Ringe, H. Lang, K.J. Oldhafer, M. Gebel, P. Flemming, A. Georgii, et al.
Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients.
Hepatology, 21 (1995), pp. 1337-1344
[112.]
P. Jara, L. Hierro, M.C. Díaz.
Indicaciones en la edad pediátrica.
Trasplante hepático, pp. 13-20
[113.]
M. Davenport, N. Kerkar, G. Mieli-Vergani, A.P. Mowat, E.R. Howard.
Biliary atresia: the King’s College Hospital experience (1974-1995).
J Pediatr Surg, 32 (1997), pp. 479-485
[114.]
R.P. Altman, J.R. Lilly, J. Greenfeld, A. Weinberg, K. Van Leeuwen, L. Flanigan.
A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twentyfive years of experience from two centers.
Ann Surg, 226 (1997), pp. 348-353
[115.]
J.B. Otte, D.G. De Ville, R. Reding, V. Hausleithner, E. Sokal, C. Chardot, et al.
Sequential treatment of biliary atresia with Kasai portoenterostomy and liver transplantation: a review.
Hepatology, 20 (1994), pp. 41-48
[116.]
B.L. Shneider.
Genetic cholestasis syndromes.
J Pediatr Gastroenterol Nutr, 28 (1999), pp. 124-131
[117.]
D. Alagille, A. Estrada, M. Hadchouel, M. Gautier, M. Odievre, J.P. Dommergues.
Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases.
J Pediatr, 110 (1987), pp. 195-200
[118.]
N. Marcus, J.H. Teckman, D.H. Perlmutter.
Alpha1-antitrypsin deficiency: from genotype to childhood disease.
J Pediatr Gastroenterol Nutr, 27 (1998), pp. 65-74
[119.]
Y.S. Genyk, J.A. Quiros, N. Jabbour, R.R. Selby, D.W. Thomas.
Liver transplantation in cystic fibrosis.
Curr Opin Pulm Med, 7 (2001), pp. 441-447
[120.]
G. Noble-Jamieson, N.D. Barnes.
Liver transplantation for cirrhosis in cystic fibrosis.
J Pediatr, 129 (1996), pp. 314
[121.]
Memoria de la Organización Nacional de Trasplantes, 2000.
Rev Esp Trasp, 10 (2001), pp. 44-54
[122.]
K.F. Yoong, B.K. Gunson, J.A. Buckels, P. McMaster, A.D. Mayer.
Repeat orthotopic liver transplantation in the 1990s: is it justified?.
Transpl Int, 11 (1998), pp. 221-223
[123.]
H.R. Doyle, F. Morelli, J. McMichael, C. Doria, L. Aldrighetti, T.E. Starzl, et al.
Hepatic Retransplantation – an analysis of risk factors associated with outcome.
Transplantation, 61 (1996), pp. 1499-1505
[124.]
J.A. Powelson, A.B. Cosimi, W.D. Lewis, R.J. Rohrer, R.B. Freeman, J.P. Vacanti, et al.
Hepatic retransplantation in New England – a regional experience and survival model.
Transplantation, 55 (1993), pp. 802-806
[125.]
A.M. D’Alessandro, R.J. Ploeg, S.J. Knechtle, J.D. Pirsch, M.D. Stegall, R. Hoffmann, et al.
Retransplantation of the liver – a seven-year experience.
Transplantation, 55 (1993), pp. 1083-1087
[126.]
T. Wong, J. Devlin, N. Rolando, N. Heaton, R. Williams.
Clinical characteristics affecting the outcome of liver retransplantation.
Transplantation, 64 (1997), pp. 878-882
[127.]
S. Balupuri, D. Manas, M. Thick, D. Talbot.
Early regrafting after primary liver transplantation carries increased risk of death.
BMJ, 318 (1999), pp. 467
[128.]
M. Facciuto, D. Heidt, J. Guarrera, C.A. Bodian, C.M. Miller, S. Emre, et al.
Retransplantation for late liver graft failure: predictors of mortality.
Liver Transpl, 6 (2000), pp. 174-179
[129.]
F. Sánchez-Bueno, F. Acosta, P. Ramírez, R. Robles, J.M. Rodríguez, V. Munitiz, et al.
Incidence and survival rate of hepatic retransplantation in a series of 300 orthotopic liver transplants.
Transplant Proc, 32 (2000), pp. 2671-2672
[130.]
R. Kashyap, A. Jain, J. Reyes, A.J. Demetris, K.A. Elmagd, S.F. Dodson, et al.
Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up.
Transplant Proc, 33 (2001), pp. 1486-1487
[131.]
L. De Carlis, A.O. Slim, A. Giacomoni, F. DiBenedetto, V. Pirotta, A. Lauterio, et al.
Liver retransplantation: indications and results over a 15-year experience.
Transplant Proc, 33 (2001), pp. 1411-1413
[132.]
J.F. Markmann, J. Gornbein, J.S. Markowitz, M.F. Levy, G.B. Klintmalm, H. Yersiz, et al.
A simple model to estimate survival after retransplantation of the liver.
Transplantation, 67 (1999), pp. 422-430
[133.]
H.R. Rosen, J.P. Madden, P. Martin.
A model to predict survival following liver retransplantation.
Hepatology, 29 (1999), pp. 365-370
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
